Tariffs are complicating regulatory compliance and driving costs for manufacturers. Ongoing global trade tensions are creating new regulatory challenges for the medical device industry due to shifting tariffs, according to GlobalData. Tariffs aimed at …

… (GLOBE NEWSWIRE) -- The "Industrial Starch Market - Focused Insights … its huge production capacity, robust industry demand, and starch modification technology … starches in food & beverages, pharmaceuticals, paper & packaging, textiles, and …

… industries including chemicals, food & beverage products and biotech and pharmaceuticals … the paint and coatings industry, is headquartered in … broader paint and coatings industry. INDCO President Mark … identify and develop industrial mixing equipment and …

… the automobile, banks, NBFCs, and pharmaceuticals sectors. The brokerage noted that … , SBI Life, Jio Financial, Reliance Industries, and ICICI Bank, as per …

… sufficient support the UK pharmaceutical industry, according to the Association of … UK’s growth ambitions for pharmaceuticals. Robust intellectual property protections are … better support Britain’s pharmaceutical industry,” Richard Torbett, ABPI Chief …

Technologies such as artificial intelligence (AI) and machine learning (ML) are advancing quickly in many industries, including the biopharmaceutical industry. One challenge in the implementation of these technologies in biopharma, according to Edwin Stone …

Ten years ago, providers were terrified to share data with health plans for fear of giving up their relationship with the patient and what payers would do with the information and now interoperability is having a favorable impact on patient care, says …

Catalyst Enters 2025 With Strong Momentum; Reiterates Confidence in Full-Year Outlook Delivers Record Q1 2025 Total Revenues of $141.4 Million, a 43.6% YoY Increase FIRDAPSE® and AGAMREE® Drive Sustained Organic Growth, Underscoring Execution Strength …

NEWTON, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s …